[1]
R. Dhar, A. Prasad, and V. Annadurai, “Triple Fixed-dose combination of Dapagliflozin, Sitagliptin, and Metformin for People with Type 2 Diabetes in Indian Settings”, J. Drug Delivery Ther., vol. 14, no. 9, pp. 66–73, Sep. 2024, doi: 10.22270/jddt.v14i9.6692.